Valgimigli, Marco <br/><br/>
Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial.  [electronic resource] 

 -  JAMA  May 2005 
 - 2109-17 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-3598 
<br/><br/><label>Standard No.: </label>10.1001/jama.293.17.2109  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abciximab<br/>Aged<br/>Angioplasty, Balloon, Coronary<br/>Antibodies, Monoclonal--therapeutic use<br/>Drug Delivery Systems<br/>Female<br/>Humans<br/>Immunoglobulin Fab Fragments--therapeutic use<br/>Immunosuppressive Agents--administration & dosage<br/>Male<br/>Middle Aged<br/>Myocardial Infarction--therapy<br/>Platelet Aggregation Inhibitors--therapeutic use<br/>Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors<br/>Single-Blind Method<br/>Sirolimus--administration & dosage<br/>Stents<br/>Tirofiban<br/>Tyrosine--analogs & derivatives